ICU Medical Inc. (ICUI)
137.39
5.11 (3.86%)
At close: Apr 24, 2025, 3:59 PM
136.11
-0.93%
After-hours: Apr 24, 2025, 07:08 PM EDT
3.86% (1D)
| Bid | 136.1 |
| Market Cap | 3.38B |
| Revenue (ttm) | 2.38B |
| Net Income (ttm) | -117.69M |
| EPS (ttm) | -4.83 |
| PE Ratio (ttm) | -28.45 |
| Forward PE | 16.16 |
| Analyst | Buy |
| Ask | 169.05 |
| Volume | 269,874 |
| Avg. Volume (20D) | 284,049 |
| Open | 133.68 |
| Previous Close | 132.28 |
| Day's Range | 133.25 - 138.15 |
| 52-Week Range | 93.36 - 196.26 |
| Beta | 0.87 |
About ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for h...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Mar 31, 1992
Employees 15,000
Stock Exchange NASDAQ
Ticker Symbol ICUI
Website https://www.icumed.com
Analyst Forecast
According to 4 analyst ratings, the average rating for ICUI stock is "Buy." The 12-month stock price forecast is $191, which is an increase of 39.02% from the latest price.
Stock ForecastsNext Earnings Release
ICU Medical Inc. is scheduled to release its earnings on May 8, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-2.28%
ICU Medical shares are trading lower. The company ...
Unlock content with
Pro Subscription
8 months ago
+24.27%
ICU Medical shares are trading higher after the company reported better-than-expected Q2 financial results.
